Uniunea Europeană - română - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - medicamente utilizate în diabet - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 și 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure.  chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

boehringer ingelheim pharma gmbh & co. kg - germania - empagliflozinum - compr. film. - 10mg - antidiabetice orale

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

boehringer ingelheim pharma gmbh&co. kg - germania - empagliflozinum - compr. film. - 25mg - antidiabetice orale